"Das Carl-von-Basedow-Klinikum ist ein modernes Haus mit einer langen Tradition. Es liegt im Herzen Mitteldeutschlands, im Ballungsgebiet Halle-Leipzig, im Süden Sachsen-Anhalts. Es ist ein Krankenhaus der Schwerpunktversorgung mit 632 Betten und einziges Krankenhaus im Saalekreis. Als alleiniger Gesellschafter der Carl-von-Basedow-Klinikum Saalekreis gGmbH fungiert der wirtschaftlich starke, kinderfreundliche Landkreis Saalekreis. Mehr als 1.300 Mitarbeiter sorgen für eine exzellente, wohnortnahe Behandlung der Patienten."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Daiichi Sankyo, Inc.
2
University of Leipzig
2
Advanz Pharma
1
Gruppo Italiano Malattie EMatologiche dell'Adulto
1
Clinical Trials at Carl-von-Basedow-Klinikum Merseburg
During the past decade, Carl-von-Basedow-Klinikum Merseburg conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Edoxaban in Patients With Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
2020-06-30
2023-06-30
Active, not recruiting
1,200
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Carl-von-Basedow-Klinikum Merseburg"
#1 collaborator was "Daiichi Sankyo Deutschland GmbH" with 1 trials as a collaborator, "Johannes Gutenberg University Mainz" with 1 trials as a collaborator and "Study Alliance Leukemia (SAL) Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Carl-von-Basedow-Klinikum Merseburg
According to Clinical.Site data, the most researched conditions in "Carl-von-Basedow-Klinikum Merseburg" are
"Atrial Fibrillation" (3 trials), "Ischemic Stroke" (1 trials), "Leukemia" (1 trials), "Non-valvular Atrial Fibrillation" (1 trials) and "ST-elevation Myocardial Infarction" (1 trials). Many other conditions were trialed in "Carl-von-Basedow-Klinikum Merseburg" in a lesser frequency.
Clinical Trials Intervention Types at Carl-von-Basedow-Klinikum Merseburg
Most popular intervention types in "Carl-von-Basedow-Klinikum Merseburg" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Edoxaban" (2 trials), "7-day Holter ECG" (1 trials), "Amiodarone Injection:" (1 trials), "Implantable cardiac monitor" (1 trials) and "Standard of care" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Carl-von-Basedow-Klinikum Merseburg
The vast majority of trials in "Carl-von-Basedow-Klinikum Merseburg" are
6 trials for "All" genders.
Clinical Trials Status at Carl-von-Basedow-Klinikum Merseburg
Currently, there are NaN active trials in "Carl-von-Basedow-Klinikum Merseburg".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Carl-von-Basedow-Klinikum Merseburg,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Carl-von-Basedow-Klinikum Merseburg, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".